Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-02

Clinical Trial Update: A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Mircera in anemic patients with chronic kidney disease not yet on dialysis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 2 | Status: COMPLETED | Results posted: 2018-01-02